Glucose and Triphenylphosphonium Co-Modified Redox-Sensitive Liposomes to Synergistically Treat Glioma with Doxorubicin and Lonidamine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Glucose and Triphenylphosphonium Co-Modified Redox-Sensitive Liposomes to Synergistically Treat Glioma with Doxorubicin and Lonidamine

Published:2021-06-01 Issue:23 Volume:13 Page:26682-26693
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Peng Yao¹,Lu Jiaqi¹,Li Ru¹,Zhao Yi²,Hai Li¹,Guo Li¹,Wu Yong¹^ORCID

Affiliation:

1. Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China

2. Department of Translational Medicine Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China

Funder

Department of Science and Technology of Sichuan Province

National Natural Science Foundation of China

Sichuan Youth Science and Technology Innovation Research Team Funding

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.1c02404

Reference36 articles.

1. Malignant Gliomas in Adults

2. Glioblastoma Treatments: An Account of Recent Industrial Developments

3. Drug Targeting to the Brain

4. Overcoming the blood–brain tumor barrier for effective glioblastoma treatment

5. Nano-Therapies for Glioblastoma Treatment

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4-Methylthiazole Triggers Apoptosis and Mitochondrial Disruption in HL-60 Cells;2024-08-22

2. Targeting mitochondrial quality control: new therapeutic strategies for major diseases;Military Medical Research;2024-08-21

3. Liposomal Nanomaterials: A Rising Star in Glioma Treatment;International Journal of Nanomedicine;2024-07

4. TPP-based conjugates: potential targeting ligands;Drug Discovery Today;2024-06

5. Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming;Cancer Letters;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3